Skip to content

Turkish Validity and Reliability Study of Virtual Reality Sickness Questionnaire

Turkish Validity and Reliability Study of Virtual Reality Sickness Questionnaire

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04483999
Enrollment
100
Registered
2020-07-23
Start date
2021-06-30
Completion date
2023-03-30
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickness Behavior

Keywords

virtual reality, sickness, validity, reliability, turkish

Brief summary

This study is planned for the cultural adaptation and validity of the Virtual Reality Sickness Questionnaire.

Detailed description

Virtual reality (SG) creates a virtual environment that reflects a real environment and offers various experiences to users. Motion sickness can be observed in people after using virtual reality applications or simulation devices in education. There are questionnaires in the literature such as Simulator Sickness Questionnaire and Motion Sickness Questionnaire. However, these questionnaires are specific surveys to evaluate symptoms that develop after vehicle handling or use of simulation devices for pilot training, while they are not ideal questionnaires to evaluate symptoms that may develop after virtual reality applications. Because there are important differences between virtual reality systems and simulation systems in terms of the appearance of motion disturbance symptoms. For this reason, Virtual Reality Sickness Questionnaire has been developed that can evaluate these symptoms. There is no Turkish version of the Virtual Reality Sickness Questionnaire in the literature. For this reason, this study is planned for the cultural adaptation and validity of the Virtual Reality Sickness Questionnaire.

Interventions

None listed

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Not having mental - cognitive problems, * Being a volunteer

Exclusion criteria

* Oculomotor and vestibular disease * Cardiovascular, neurological and gastrointestinal problems

Design outcomes

Primary

MeasureTime frameDescription
Virtual Reality Sickness QuestionnaireChange from Baseline sickness after 1 hour later.This questionnaire assess virtual reality sickness. This questionnaire consists of 2 subtitles as oculomotor and disorientation. It contains 9 symptoms in total. Each symptom is scored between 0 and 3 with the Likert type scoring system. Each subtitle adapted to be calculated by dividing the total score to a score system in itself like person receives%. The total score of the questionnaire will be obtained by averaging the total scores of the two subtitles.
graybiel scaleChange from Baseline sickness after 1 hour later.This questionnaire assess virtual reality sickness. Total score ranges from 0-50. 0-2 points are interpreted as light susceptibility to motion sickness, 3-7 points as moderate susceptibility to motion sickness, 8-15 points as extreme susceptibility to motion sickness, and values above 16 are Definitive motion sickness.

Secondary

MeasureTime frameDescription
international physical activity questionnaireAll of the participants will assess at baseline with this scale.This questionnaire assess physical activity level. The physical activity levels are classified as (\< 600 MET-min/week), which is the physically inactive level (level I); (600-3000 METmin/week), which is the level in medium-level (level II) and (\> 3000 MET-min/week), which is the high physical activity level.
tampa kinesiophobia scaleAll of the participants will assess at baseline with this scale.This questionnaire assess kinesiophobia. The four-point Likert scoring is used in this scale (1 = I do not agree at all, 4 = I agree completely). The total score is calculated after reversing the items 4, 8, 12 and 16. Scoring ranges between 17 and 68 with the higher scores indicating higher levels of kinesiophobia perception.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026